be_ixf;ym_202002 d_18; ct_50
Loading Events

« All Events

  • This event has passed.

Angiotensin II for Vasodilatory Shock: Past, Present and Future

January 22

Click Here to Access OnDemand Recording 

Click Here to Access Evaluation 

1.22.20 PowerPoint

Angiotensin II for Vasodilatory Shock: Past, Present and Future

Presented By: Michael McCurdy, MD

Learning Objectives: 

  • Define shock and characterize its key components
  • Highlight mechanism and significance of maintaining MAP
  • Discuss the history and role of angiotensin II in the management of vasodilatory shock

 

After graduating magna cum laude from the University of Notre Dame, Dr. McCurdy completed his medical training at the University of Texas Medical School at San Antonio. He subsequently pursued a dual residency in Internal Medicine and Emergency Medicine, in which he served as chief resident, followed by a Critical Care Medicine fellowship, all at the University of Maryland Medical Center. Dr. McCurdy is board-certified in Emergency Medicine, Internal Medicine, and Critical Care Medicine.  Dr. McCurdy is an associate professor of both Pulmonary & Critical Care Medicine and Emergency Medicine at The University of Maryland School of Medicine.

 

 

Accreditation Statement: The Beacon Health System is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.

Designation Statement: Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure: Physician(s) and all planners associated with this activity do not have any potential conflict of interest.

Disclosure Statement: As a CME provider accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs. All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufactures, or other corporations whose products or services are related to the subject matter of the presentation topic.

Commercial Support: No commercial support was used in planning or implementation of the CME activity.

On Demand Details: Recordings are available for credit until 1/22/2021

Questions may be directed to Jenai White at 574.524.7280 or mewhite@beaconhealthsystem.org

Details

Date:
January 22
Event Categories:
, ,

Venue

On Demand